Bangladesh · Delayed Price · Currency is BDT Ambee Pharmaceuticals Statistics
Total Valuation
DSE:AMBEEPHA has a market cap or net worth of BDT 1.89 billion. The enterprise value is 2.37 billion.
| Market Cap | 1.89B |
| Enterprise Value | 2.37B |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DSE:AMBEEPHA has 2.40 million shares outstanding.
| Current Share Class | 2.40M |
| Shares Outstanding | 2.40M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 77.25% |
| Owned by Institutions (%) | n/a |
| Float | 545,941 |
Valuation Ratios
The trailing PE ratio is 187.31.
| PE Ratio | 187.31 |
| Forward PE | n/a |
| PS Ratio | 8.03 |
| PB Ratio | 58.57 |
| P/TBV Ratio | 58.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 107.32, with an EV/FCF ratio of -31.91.
| EV / Earnings | 235.48 |
| EV / Sales | 10.09 |
| EV / EBITDA | 107.32 |
| EV / EBIT | 181.23 |
| EV / FCF | -31.91 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 19.37.
| Current Ratio | 0.91 |
| Quick Ratio | 0.50 |
| Debt / Equity | 19.37 |
| Debt / EBITDA | 28.23 |
| Debt / FCF | -8.39 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 35.50% and return on invested capital (ROIC) is 1.45%.
| Return on Equity (ROE) | 35.50% |
| Return on Assets (ROA) | 1.27% |
| Return on Invested Capital (ROIC) | 1.45% |
| Return on Capital Employed (ROCE) | 36.40% |
| Revenue Per Employee | 444,644 |
| Profits Per Employee | 19,052 |
| Employee Count | 529 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 0.51 |
Taxes
In the past 12 months, DSE:AMBEEPHA has paid 3.44 million in taxes.
| Income Tax | 3.44M |
| Effective Tax Rate | 25.44% |
Stock Price Statistics
The stock price has decreased by -8.32% in the last 52 weeks. The beta is -0.39, so DSE:AMBEEPHA's price volatility has been lower than the market average.
| Beta (5Y) | -0.39 |
| 52-Week Price Change | -8.32% |
| 50-Day Moving Average | 816.50 |
| 200-Day Moving Average | 784.77 |
| Relative Strength Index (RSI) | 41.84 |
| Average Volume (20 Days) | 2,097 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:AMBEEPHA had revenue of BDT 235.22 million and earned 10.08 million in profits. Earnings per share was 4.20.
| Revenue | 235.22M |
| Gross Profit | 124.78M |
| Operating Income | 13.10M |
| Pretax Income | 13.52M |
| Net Income | 10.08M |
| EBITDA | 21.91M |
| EBIT | 13.10M |
| Earnings Per Share (EPS) | 4.20 |
Balance Sheet
The company has 138.89 million in cash and 624.31 million in debt, giving a net cash position of -485.42 million or -202.26 per share.
| Cash & Cash Equivalents | 138.89M |
| Total Debt | 624.31M |
| Net Cash | -485.42M |
| Net Cash Per Share | -202.26 |
| Equity (Book Value) | 32.23M |
| Book Value Per Share | 13.43 |
| Working Capital | -65.11M |
Cash Flow
In the last 12 months, operating cash flow was -50.27 million and capital expenditures -24.09 million, giving a free cash flow of -74.37 million.
| Operating Cash Flow | -50.27M |
| Capital Expenditures | -24.09M |
| Free Cash Flow | -74.37M |
| FCF Per Share | -30.99 |
Margins
Gross margin is 53.05%, with operating and profit margins of 5.57% and 4.28%.
| Gross Margin | 53.05% |
| Operating Margin | 5.57% |
| Pretax Margin | 5.75% |
| Profit Margin | 4.28% |
| EBITDA Margin | 9.32% |
| EBIT Margin | 5.57% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.13%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.13% |
| Dividend Growth (YoY) | -33.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.81% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.13% |
| Earnings Yield | 0.53% |
| FCF Yield | -3.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 29, 2014. It was a forward split with a ratio of 1.2.
| Last Split Date | May 29, 2014 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
DSE:AMBEEPHA has an Altman Z-Score of 1.86 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.86 |
| Piotroski F-Score | 3 |